Sema4 Goes Public via SPAC Merger

MedCity News interviewed Sema4 Founder and CEO Eric Schadt on Sema4 going public through a special purpose acquisition company transaction. Among other things, the article outlines Sema4’s approach to precision medicine, its key differentiators, and its plans to further improve the standard of care.